中文 | English
Return
Total: 20 , 1/2
Show Home Prev Next End page: GO
MeSH:(Hepatitis C, Chronic/*drug therapy/etiology)

1.Occurrence and recurrence of hepatitis C-related hepatocellular carcinoma after direct antiviral treatment.

Yu Qing YANG ; Xiao Yuan XU

Chinese Journal of Hepatology 2022;30(1):103-106

4.Chronic Hepatitis C and Insulin Resistance.

Woo Jin CHUNG

The Korean Journal of Gastroenterology 2012;59(4):268-274

6.Clinical features of antiviral therapy in 12 patients with hepatitis C virus-related cirrhosis after splenectomy.

Li-na MA ; Zhi-min HE ; Wei HUA ; Xin-yue CHEN

Chinese Journal of Hepatology 2013;21(8):594-598

7.Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C.

Yun Nah LEE ; Soung Won JEONG ; Jae Hee LIM ; Yang Seon RYU ; Seong Ran JEON ; Sang Kyun KIM ; Jae Young JANG ; Young Seok KIM ; Boo Sung KIM ; Mi Oh ROH

The Korean Journal of Hepatology 2010;16(2):187-191

9.Cryoglobulinemia is an independent factor negatively associated with sustained virological response in chronic hepatitis C patients.

Xiao-hong FAN ; Chi-hong WU ; Li-fen WANG ; Ying-ying ZHENG ; Ying YAO ; Hai-ying LU ; Xiao-yuan XU ; Lai WEI

Chinese Medical Journal 2012;125(22):4014-4017

10.Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea.

Yuri CHO ; Eun Ju CHO ; Jeong Hoon LEE ; Su Jong YU ; Jung Hwan YOON ; Yoon Jun KIM

Clinical and Molecular Hepatology 2015;21(4):358-364

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 20 , 1/2 Show Home Prev Next End page: GO